Opus Genetics, Inc. Increase (Decrease) in Accounts Payable
Opus Genetics, Inc. (IRD) reported Increase (Decrease) in Accounts Payable of -$1.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Opus Genetics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$2.57M.
- Opus Genetics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.16M.
- Opus Genetics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $804.00K, a 47.76% decline year-over-year.
- Opus Genetics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $906.00K, a 353.00% increase year-over-year.
- Opus Genetics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $7.00K, a 96.82% decline from fiscal 2024.
- Opus Genetics, Inc. increase (decrease) in accounts payable for fiscal 2024 was $220.00K, a 79.67% decline from fiscal 2023.
- Opus Genetics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.08M.
- Opus Genetics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$515.00K, a 235.17% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.41M 10-Q · filed 2026-08-06 | -$608.00K derived: sum of 3 quarters · filed 2026-08-06 | $298.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-12 | $1.96M derived: sum of 2 quarters · filed 2026-05-12 | $2.87M derived: sum of 3 quarters · filed 2026-05-12 | $1.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.71M derived: sum of 2 quarters · filed 2026-03-12 | $725.00K derived: sum of 3 quarters · filed 2026-08-06 | $7.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $906.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$79.00K derived: sum of 2 quarters · filed 2026-08-06 | -$797.00K 10-Q · filed 2025-11-12 | $742.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.70M 10-Q · filed 2026-08-06 | -$164.00K derived: sum of 3 quarters · filed 2026-08-06 | $36.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$718.00K 10-Q · filed 2026-05-12 | $821.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.02M derived: sum of 3 quarters · filed 2026-05-12 | -$409.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.74M derived: sum of 2 quarters · filed 2026-03-12 | $309.00K derived: sum of 3 quarters · filed 2026-03-12 | $220.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.23M derived: sum of 2 quarters · filed 2025-11-12 | -$1.32M 10-Q · filed 2025-11-12 | -$946.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$1.52M 10-Q · filed 2025-08-13 | -$1.15M derived: sum of 3 quarters · filed 2025-08-13 | -$1.69M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$89.00K 10-Q · filed 2025-05-15 | $284.00K derived: sum of 2 quarters · filed 2025-05-15 | -$261.00K derived: sum of 3 quarters · filed 2025-05-15 | -$159.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$172.00K derived: sum of 2 quarters · filed 2025-03-31 | -$70.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.08M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$443.00K derived: sum of 2 quarters · filed 2024-11-12 | $709.00K 10-Q · filed 2024-11-12 | $319.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.25M 10-Q · filed 2024-08-13 | $864.00K derived: sum of 3 quarters · filed 2024-08-13 | $437.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.15M 10-Q · filed 2024-05-10 | $762.00K derived: sum of 2 quarters · filed 2024-05-10 | $335.00K derived: sum of 3 quarters · filed 2024-05-10 | $642.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$817.00K derived: sum of 2 quarters · filed 2024-03-08 | -$510.00K derived: sum of 3 quarters · filed 2024-03-08 | -$515.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | -$427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$120.00K derived: sum of 2 quarters · filed 2023-11-13 | -$125.00K 10-Q · filed 2023-11-13 | $40.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $302.00K 10-Q · filed 2023-08-11 | $467.00K derived: sum of 3 quarters · filed 2023-08-11 | $522.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$5.00K 10-Q · filed 2023-05-15 | $160.00K derived: sum of 2 quarters · filed 2023-05-15 | $215.00K derived: sum of 3 quarters · filed 2023-05-15 | $176.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $220.00K derived: sum of 2 quarters · filed 2023-03-30 | $181.00K derived: sum of 3 quarters · filed 2023-03-30 | $381.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $16.00K derived: sum of 2 quarters · filed 2022-11-04 | $216.00K 10-Q · filed 2022-11-04 | $794.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $161.00K 10-Q · filed 2022-08-12 | $739.00K derived: sum of 3 quarters · filed 2022-08-12 | $775.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-13 | $778.00K derived: sum of 2 quarters · filed 2022-05-13 | $814.00K derived: sum of 3 quarters · filed 2022-05-13 | $982.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $614.00K derived: sum of 2 quarters · filed 2022-03-24 | $782.00K derived: sum of 3 quarters · filed 2022-03-24 | $792.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $204.00K derived: sum of 2 quarters · filed 2021-11-12 | $214.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $178.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $10.00K 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$168.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |